July 2011 Update of Registered Ethics Committees.
According to the Chairman of NHREC, Professor Clement Adebamowo, these are the committees that have met the minimum requirement for registration as functional ethics committees in Nigeria and whose composition and operations meet the conditions specified in the National Code for Health Research Ethics (NCHRE). The Code requires that these committees be audited every 2 years so some may be dropped or their categorization change while new committees will be added as they complete the registration process.
|
Colour Key |
||
|
Authorization |
Category / Colour Code |
Exclusions |
|
Authorised to review all types of research |
A |
None |
|
Authorised to review Phases II, III and IV clinical trials, vaccines and biological products trials, genetic, social and behavioural research, alternative and complementary medicines and epidemiological studies. Also authorised to review trials in vulnerable populations |
B |
Novel products with potential nation-wide religious, social and security implications and research including use of radioactive pharmaceuticals should be referred to NHREC |
|
Authorised to review Phases III and IV clinical trials, social and behavioural research, alternative and complementary medicines and epidemiological studies. Also authorised to review trials in vulnerable populations |
C1 |
In addition to exclusions for categories A and B, Phase I and II clinical trials, vaccines and biological research, genetic research |
|
Authorized to review Phases III and IV clinical trials including those in vulnerable populations ONLY IF the studies have been reviewed and approved by the Ethics Committees at the Clinical Sites where the studies are to be conducted. Also authorised to review social and behavioural research, trials on alternative and complementary medicines trials as well as epidemiological studies |
C2 |
In addition to exclusions for categories A and B, Phase I and II clinical trials, vaccines and biological research, genetic research. (This category applies to organizations without clinical facilities but whose staff engage in clinical research in collaboration with clinical sites.) |
|
Authorised to review Phases III and IV clinical trials excluding those in vulnerable populations, social and behavioural research and epidemiological studies. |
D1 |
In addition to exclusions for categories above, complementary and alternative medicines research and research among vulnerable populations |
|
Authorized to review Phases III and IV clinical trials excluding those in vulnerable populations ONLY IF the studies have been reviewed and approved by the Ethics Committees at the Clinical Sites where the studies are to be conducted. Also authorised to review social and behavioural research and epidemiological studies |
D2 |
In addition to exclusions for categories above, complementary and alternative medicines research and research among vulnerable populations. (This category applies to organizations without clinical facilities but whose staff engage in clinical research in collaboration with clinical sites.) |
|
Authorised to review only epidemiological, social and behavioural studies. No clinical trials authorization |
E |
In addition to exclusions for categories above, this committee is not allowed to review ANY clinical trial |
